Back to Search
Start Over
Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis.
- Source :
-
Cancer (0008543X) . Jul2017, Vol. 123 Issue 14, p2600-2603. 5p. - Publication Year :
- 2017
-
Abstract
- High‐risk mutations are associated with poor response to interferon‐α2. Early treatment with interferon‐α2 is recommended in patients who have early myelofibrosis without high‐risk mutations. See also pages 2680‐7. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 0008543X
- Volume :
- 123
- Issue :
- 14
- Database :
- Academic Search Index
- Journal :
- Cancer (0008543X)
- Publication Type :
- Academic Journal
- Accession number :
- 123928440
- Full Text :
- https://doi.org/10.1002/cncr.30676